Time for round 2: Il­lu­mi­na-backed VC snags $325M for its next fund

Il­lu­mi­na Ven­tures closed off its sec­ond in­vest­ment fund with a to­tal com­mit­ment of $325 mil­lion, of­fer­ing fresh fu­el to back a slate of star­tups that have al­ready in­clud­ed a smor­gas­bord of com­pa­nies, cov­er­ing every­thing from di­ag­nos­tics to biotech drug de­vel­op­ment and ge­nomics.

Fund II brings the to­tal in­vest­ment un­der Il­lu­mi­na Ven­tures’ over­sight to $560 mil­lion, which has been fo­cused on ear­ly-stage com­pa­nies. And it has a transat­lantic port­fo­lio that in­cludes SQZ, Twist and En­cod­ed Ther­a­peu­tics.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER